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Summary
Objective: Full-thickness defects that penetrate articular cartilage are filled by fibrous, or fibrocartilaginous tissue and, to a very limited extent,
also by hyaline cartilage. In rabbits, small full-thickness defects (to 53 mm in diameter) are capable of regenerating surfacing hyaline
cartilage. However, chondrogenic differentiation does not occur in larger defects (~5 mm in diameter). We studied the involvement of
fibroblast growth factor-2 (FGF-2) in the cartilaginous repair response in full-thickness defects of articular cartilage in vivo, and attempted to
facilitate cartilaginous repair of the defects by the local administration of FGF-2.
Design: The right knee joint of male adolescent Japanese white rabbits was entered through a medial parapatellan approach, and the patella
was dislocated laterally to expose the articular surface of the femoral trochlea. Full-thickness defects were created in the weight·bearing area
of the femoral trochlea with a hand-drill (the 5-mm diameter defects in 80 rabbits and the 3-mm diameter defects in 40 rabbits). The animals
were fitted with an osmotic pump connected to silastic medical grade tubing, and a length of the tubing about 5 mm long was introduced into
the articular knee cavity. The 5-mm-diameter defects received FGF·2 (50 pg/h) or sterile saline via an osmotic pump for the initial 2 weeks.
Five animals each were sacrificed after 1, 2, 4, 8, or 24 weeks after creation of defects. The 3-mm diameter defects received a neutralizing
monoclonal antibody against FGF-2 (50 nglh) or pre-immune mouse IgG (50 nglh) for the initial 2 weeks. Five animals each were sacrificed
after 2, 3, or 4 weeks after creation of defects. The distal portion of each femur was removed, fixed, decalcified, and embedded in paraffin
for the subsequent histological analysis. Sections were cut in the transverse plane, and histologically examined.
Results: The administration of FGF-2 (50 pg/h) resulted in successful regeneration of articular cartilage and the subchondral bone within 8
weeks after creation of 5-mm diameter defects. In these defects, undifferentiated mesenchymal cells initiated chondrogenic differentiation
coupled with replacement by subchondral bone, resulting in the resurfacing of the defects by hyaline cartilage and the recovery of
subchondral bone up to the original bone-articular cartilage junction. In contrast, the administration of a neutralizing monoclonal antibody
against FGF-2 clearly interfered with the action of endogenous FGF-2 in 3-mm diameter defects, which were filled with fibrous tissue. None
of the antibody-treated defects were covered with cartilage. We then assessed the proliferative capacity of the undifferentiated mesenchymal
cells in the defects by immunostaining the proliferating cell nuclear antigen (PCNA) at 1 week after creation of defects. The capacity of
reparative tissue to form cartilage was well correlated with the occurrence in the defects of a cell population that was PCNA-positive,
undifferentiated, and capable of self-renewal.
Conclusions: The local administration of FGF-2 resulted in the successful resurfacing of large (5 mm in diameter) defects by hyaline
cartilage. Prechondrogenic mesenchymal cells were the likely targets of FGF-2, which probably promoted the formation of cartilage by
stimulating a selective expansion of chondroprogenitor cells. Thus, activation of FGF-2 signalling is critically important for the induction of
cartilaginous repair response in full-thickness articular cartilage. © 2001 OsteoArthritis Research Society International
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Introduction
During the development of skeletal elements, cartilage
appears to form by chondrogenic differentiation after con-
densation of mesenchymal cells in particular regions of
future skeletal elements. During cartilage formation, chon-
droprogenitor cells pass through at least three distinct
differentiation stages: (1) prechondrocytes found in the
regions of cellular condensation, (2) proliferating chondro-
cytes, and (3) hypertrophic and calcified chondrocytes1 .
Fundamental insight into the regulation of cartilage for-
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mation has been gained from the cultures of chick limb
mesenchymal cells in vitrcl-. However, the molecular analy-
sis awaits the establishment of a clonal cell line capable
of efficient chondrogenic differentiation in vitro. Previously,
we demonstrated that mouse cell line ATDC5 in vitro
initially retained properties of chondroprogenitor cells and,
thereafter, underwent the multistep differentiation into
chondrocytes3.4 •
As summarized in Fig. 1, differentiation of ATDC5 cells
was initiated by the formation of cellular condensation in
the presence of insulin or insulin-like growth factor-I (IGF-I).
Cellular condensation limits the region of chondrogenic
differentiation to occur. The progression of the differen-
tiation programme was positively regulated by bone
morphogenetic protein (BMP) and negatively regulated by
parathyroid hormone-related peptide (PTHrp)3.5,6. We pre-
viously .demonstrated that ATDC5 cells acquired the






